Biomarker testing
Biomarker testing has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 27, 2026: “The future of prostate cancer screening: from prostate-specific antigen to smart, risk-adapted pathways”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1 papers on biomarker testing
What is biomarker testing linked with?
1Studies link biomarker testing with Prostate cancer rule-out performance.
Prostate cancer rule-out performance
upin humans1
1 study
Prostate cancer rule-out performance
upin humans1
Biomarker testing is associated with prostate cancer rule-out performance in humans (90–95% sensitivity).
“Biomarker testing offers objective, reproducible rule-out performance (90–95% sensitivity) and greater accessibility compared to MRI, though has limited specificity.”
Reviewblood- or urine-basedmales
Current opinion in urology